Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Mantis Photonics

""

Millions of people worldwide are affected by Alzheimers Disease, and the fatality is increasing. With limited treatment available, early screening is the key to success.

Based on research from Lund University, Mantis Photonics is developing a new technique of hyperspectral retinal imaging, allowing Alzheimers Disease to be diagnosed through the eye's colour. 

The patented Mantis Hyperspectral Camera can detect Amyloid beta, a biomarker of Alzheimer, through retinal imaging. This solution is low cost, multi-purpose and efficient.

 

Mantis Photonics website

Mantis Photonics

New imaging technique for screening of Alzheimer Disease.

Founded by Diego Guénot and Denis Hellebuyck.

Portfolio company since 2021.

Portfolio Manager LU Holding:

eddie [dot] thordarson [at] innovation [dot] lu [dot] se (Eddie Thordarson), phone +46 70 874 99 02